Improving HIV/AIDS Surveillance and Program Evaluation in the Republic of Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH13 135204CONT17

Opportunity Information: Apply for CDC RFA GH13 135204CONT17

This funding opportunity, titled "Improving HIV/AIDS Surveillance and Program Evaluation in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. government public health grant administered by the Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC), specifically under CDC's Center for Global Health (CGH). The program sits within the health funding activity category and is aligned with PEPFAR, the U.S. initiative that supports global HIV prevention, treatment, and related health systems strengthening. The core intent of the opportunity is to support work in Cote d'Ivoire that improves HIV/AIDS surveillance and strengthens the ability to evaluate HIV programs, which typically includes the systems and methods used to track the epidemic, monitor outcomes, and ensure that resources are targeted effectively.

The announcement is identified by Funding Opportunity Number CDC RFA GH13-135204CONT17 and is categorized as "Continuation," meaning it is designed to extend or continue an existing line of work rather than launch an entirely new program from scratch. The funding instrument is a cooperative agreement, which signals that CDC expects to have substantial involvement in the funded activities. In practice, cooperative agreements usually involve close technical collaboration, shared planning, and ongoing coordination between the recipient and CDC staff, rather than a more hands-off relationship that is common in some standard grants.

From an administrative standpoint, the opportunity is associated with CFDA number 93.067, which corresponds to CDC global health-related assistance. The opportunity record shows an award ceiling of 0, which commonly indicates that a specific maximum award amount is not listed in the summary record, may be determined through the continuation process, or is otherwise defined in accompanying guidance rather than in the top-line synopsis. The expected number of awards is listed as 10, suggesting that CDC anticipated supporting multiple recipients or multiple continuation actions under this umbrella, depending on eligibility, program needs, and available funds.

Eligibility is described broadly as "Others," with a note directing applicants to consult the additional eligibility information in the full announcement text. That phrasing typically means eligibility could include a range of organizations beyond the standard categories, potentially including international entities, local organizations, academic institutions, non-governmental organizations, or other partners engaged in HIV surveillance and evaluation work. Because this is a continuation opportunity, eligibility may also be constrained to current or prior recipients or to entities that meet specific partnership or performance conditions described in the full notice.

Key dates included in the record indicate the opportunity was created on October 10, 2016, with an original closing date of December 13, 2016. Those dates place the announcement in a defined application window and suggest that submissions were required within about two months of posting. The focus on surveillance and program evaluation implies support for activities such as strengthening HIV case reporting and related data systems, improving the quality and use of routine program data, enhancing monitoring and evaluation frameworks, training staff in epidemiology and data analysis, and supporting evaluation studies that help determine what interventions are working and where gaps remain. In a PEPFAR context, this kind of work generally aims to improve data-driven decision-making, track progress toward treatment and prevention goals, and ensure accountability for results.

Overall, this opportunity represents CDC support, through a cooperative agreement mechanism, for partners working in Cote d'Ivoire to improve the public health information infrastructure and evaluation capacity needed to guide and assess HIV/AIDS programs under PEPFAR.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Improving HIV/AIDS Surveillance and Program Evaluation in the Republic of Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 10, 2016.
• Applicants must submit their applications by Dec 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH13 135204CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: